Puromycin aminonucleoside

Catalog No.S9631 Batch:S963101

Print

Technical Data

Formula

C12H18N6O3
Molecular Weight 294.31 CAS No. 58-60-6
Solubility (25°C)* In vitro DMSO 59 mg/mL (200.46 mM)
Water 30 mg/mL (101.93 mM)
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Puromycin aminonucleoside (NSC 3056, PAN, Stylomycin aminonucleoside, ARDMA, SAN), the aminonucleoside portion of the antibiotic puromycin, is a reversible inhibitor of dipeptidyl-peptidase II and cytosol alanyl aminopeptidase that induces apoptosis in mesangial cells (MCs) accompanied by declined cell viability and enhanced inflammatory response.
Targets
DPP-2 [1] cytosol alanyl aminopeptidase [1]
In vitro

Puromycin aminonucleoside (PAN) induces MC apoptosis accompanied by the declined cell viability and enhanced inflammatory response. In PAN-treated MCs, ERRα overexpression further aggravates PAN-induced apoptosis.[1]
In vivo

In agreement with the in vitro study, increased ERRα expression is observed in line with enhanced apoptotic response in renal cortex from PAN-treated rats.[1]

Protocol (from reference)

Cell Assay:

[1]
  • Cell lines

    mouse mesangial cells

  • Concentrations

    50 μg/ml, 100 μg/ml

  • Incubation Time

    24 h

  • Method

    For apoptosis assay, mesangial cells are treated with PAN for 24 h at the indicated concentration. After treatment, cells are stained with FITC-Annexin V and PI according to the manufacturer’s protocol. Cell apoptosis is determined using a BD FACS Calibur flow cytometer and data is analyzed with Flowjo software.
Animal Study:

[1]
  • Animal Models

    male Sprague-Dawley rats

  • Dosages

    150 mg/kg

  • Administration

    IV

Selleck's Puromycin aminonucleoside has been cited by 4 publications

Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO [ Cell Mol Biol Lett, 2023, 28(1):62] PubMed: 37525118
Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO [ Cell Mol Biol Lett, 2023, 28(1):62] PubMed: 37525118
SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT [ Oral Dis, 2022, 10.1111/odi.14321] PubMed: 35894087
PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation [ Biochim Biophys Acta Mol Basis Dis, 2018, 1864(5 Pt A):1754-1769] PubMed: 29510196

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.